May 21, 2019 DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a global digital therapeutics innovator, today announced that it intends to offer and sell shares of common stock (or pre-funded...
|
May 13, 2019 - Earnings and business update call scheduled for 9:00 am ET today Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported record financial and operational results for the first quarter ended March 31, 2019. CEO, Erez Raphael,...
|
May 7, 2019 Earnings Discussion and Business Update Scheduled for 9:00 am EDT Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its first quarter 2019 results on Monday, May 13, and host a conference call the same...
|
May 3, 2019 DarioHealth's mission is to support people with diabetes and other chronic conditions in the U.S. and around the world. Dario is proud to align its efforts with those of the American Diabetes Association (ADA) to increase awareness of diabetes and its risk factors, and to support those living with diabetes and their loved ones Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced that it is partnering with the American Diabetes Association as a Living Red Sponsor of NYC - Step Out®:...
|
Dario's mission is aligned with the DTA's mission of improving healthcare quality, outcomes, and value through optimizing the use and integration of digital therapeutics Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced that it is now a member of the Digital Therapeutics Alliance (DTA) (www.DTxAlliance.org). Dario's...
|
Apr 10, 2019 New version V4.2.0 is a testament to Dario's relentless commitment to patients with chronic conditions. Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced the launch of a new version of its acclaimed Dario® system and DarioEngage™ platform. The enhancements...
|
Apr 1, 2019 The 'Per Engaged Member Per Month' (PEMPM) model is value-driven, simple and effective to cover the needs of providers and their patients Global #digitaltherapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced an agreement with Cupertino-based Auer Integrative Health's Functional Medicine and Chiropractic, a Silicon...
|
The Dario® Blood Glucose Monitoring System will be made available to hospitals and health systems using Glytec's virtual insulin titration service for outpatients with diabetes Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced a joint marketing agreement with Glytec, the market leader and pioneer of insulin titration solutions for...
|
Mar 25, 2019 Conference Call Scheduled for 9:00 am ET today Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported record financial and operational results for the full-year ended on December 31, 2018. Financial Highlights...
|
Mar 20, 2019 Significant expansion of Dario's Canadian market opportunity to include iPhone 7, 8, and iPhone X user Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), announced today the receipt of a license from Health Canada to sell its Dario™ Blood Glucose Monitoring System for...
|
Mar 18, 2019 Earnings Discussion and Business Update Scheduled for 9:00 am EDT Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its fourth quarter and year-end 2018 results on Monday, March 25, and host a...
|
Jan 2, 2019 DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has signed an agreement with Better Living Now (BLN), a...
|
| |